Northwestern Mutual Investment Management Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Buy
56,647
+95
+0.2% +$20.4K 0.17% 37
2026
Q1
$12.3M Buy
56,552
+80
+0.1% +$17.7K 0.19% 33
2025
Q4
$12.9M Buy
56,472
+167
+0.3% +$38K 0.15% 31
2025
Q3
$13M Sell
56,305
-44
-0.1% -$8.96K 0.19% 32
2025
Q2
$10.5M Buy
56,349
+202
+0.4% +$37.5K 0.16% 33
2025
Q1
$11.8M Buy
56,147
+38
+0.1% +$7.39K 0.19% 31
2024
Q4
$9.97M Buy
56,109
+126
+0.2% +$23.2K 0.22% 32
2024
Q3
$11.1M Sell
55,983
-214
-0.4% -$39.9K 0.26% 29
2024
Q2
$9.64M Buy
56,197
+174
+0.3% +$28.8K 0.25% 30
2024
Q1
$10.2M Buy
56,023
+140
+0.3% +$24.1K 0.27% 29
2023
Q4
$8.66M Buy
55,883
+172
+0.3% +$25.1K 0.23% 31
2023
Q3
$8.3M Buy
55,711
+58
+0.1% +$8.52K 0.22% 30
2023
Q2
$7.5M Buy
55,653
+63
+0.1% +$9.24K 0.2% 33
2023
Q1
$8.86M Buy
55,590
+162
+0.3% +$24.8K 0.23% 27
2022
Q4
$8.96M Sell
55,428
-10,243
-16% -$1.57M 0.23% 28
2022
Q3
$8.81M Sell
65,671
-12,547
-16% -$1.8M 0.22% 29
2022
Q2
$12M Sell
78,218
-17
-0% -$2.6K 0.27% 24
2022
Q1
$12.7M Sell
78,235
-9,322
-11% -$1.35M 0.28% 32
2021
Q4
$11.9M Sell
87,557
-1,005
-1% -$119K 0.23% 39
2021
Q3
$9.55M Buy
88,562
+8,354
+10% +$955K 0.19% 48
2021
Q2
$9.04M Buy
80,208
+154
+0.2% +$17.3K 0.16% 52
2021
Q1
$8.66M Sell
80,054
-16,832
-17% -$1.8M 0.15% 52
2020
Q4
$10.4M Buy
96,886
+73
+0.1% +$7.01K 0.14% 51
2020
Q3
$9.51M Hold
96,813
0.13% 48
2020
Q2
$9.51M Sell
96,813
-78,919
-45% -$6.95M 0.13% 47
2020
Q1
$13.4M Buy
175,732
+118,287
+206% +$10.1M 0.2% 51
2019
Q4
$5.09M Buy
57,445
+1,142
+2% +$94.8K 0.09% 79
2019
Q3
$4.26M Buy
56,303
+229
+0.4% +$15.7K 0.09% 86
2019
Q2
$4.08M Sell
56,074
-168,074
-75% -$13.2M 0.1% 87
2019
Q1
$18.1M Sell
224,148
-2,937
-1% -$240K 0.33% 68
2018
Q4
$20.9M Sell
227,085
-37,898
-14% -$3.33M 0.35% 53
2018
Q3
$25.1M Sell
264,983
-25,225
-9% -$2.39M 0.38% 57
2018
Q2
$26.9M Buy
290,208
+47
+0% +$4.59K 0.4% 48
2018
Q1
$27.5M Sell
290,161
-69,905
-19% -$7.68M 0.46% 43
2017
Q4
$34.8M Buy
360,066
+2,669
+0.7% +$252K 0.58% 37
2017
Q3
$31.8M Sell
357,397
-7,820
-2% -$595K 0.52% 41
2017
Q2
$26.5M Buy
365,217
+43,018
+13% +$2.89M 0.45% 43
2017
Q1
$21M Buy
322,199
+135,590
+73% +$8.52M 0.37% 47
2016
Q4
$11.7M Buy
186,609
+25,493
+16% +$1.56M 0.23% 49
2016
Q3
$10.2M Sell
161,116
-118,797
-42% -$7.69M 0.21% 51
2016
Q2
$17.3M Sell
279,913
-373,610
-57% -$22.8M 0.37% 51
2016
Q1
$37.3M Sell
653,523
-22,300
-3% -$1.24M 0.81% 27
2015
Q4
$40M Buy
675,823
+147,091
+28% +$8.47M 0.85% 25
2015
Q3
$28.8M Buy
528,732
+310,037
+142% +$20.2M 0.61% 37
2015
Q2
$14.7M Sell
218,695
-470,823
-68% -$30.7M 0.3% 71
2015
Q1
$40.4M Buy
+689,518
New +$41.7M 0.82% 18

Other funds holding ABBV

Northwestern Mutual Investment Management Company's ABBV Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $20.4K and bringing the position to 56,647 shares worth $14.3M. The position accounts for 0.17% of the portfolio, ranked #37.

Northwestern Mutual Investment Management Company first reported a position in ABBV in Q1 2015 and has held it in 46 quarters since. The position peaked at $40.4M in Q1 2015. 3,391 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 56,647 shares of AbbVie worth $14.3M as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 95 AbbVie shares in Q2 2026, an estimated $20.4K.
  • AbbVie made up 0.17% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #37 holding.
  • Northwestern Mutual Investment Management Company first reported a position in AbbVie in Q1 2015 and has held it in 46 quarters since.
  • Northwestern Mutual Investment Management Company's AbbVie position peaked at $40.4M in Q1 2015.
  • 3,391 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.